Hyperinsulinaemia and Alzheimer's disease.

Hyperinsulinaemia and Alzheimer's disease.

Because the aetiology of Alzheimer's disease (AD) remains unclear, and fasting hyperinsulinaemia has been incriminated in several human diseases, we examined the relationship between AD, fasting plasma insulin, glucose, body mass index and waist: hip ratio in 24 men and 24 women aged 58-90 year...

Bibliografiset tiedot
Päätekijät:	Razay, G, Wilcock, G
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	1994

Samankaltaisia teoksia

Galantamine in Alzheimer's disease.
Tekijä: Razay, G, et al.
Julkaistu: (2008)

The metabolic syndrome and Alzheimer disease.
Tekijä: Razay, G, et al.
Julkaistu: (2007)

Obesity, abdominal obesity and Alzheimer disease.
Tekijä: Razay, G, et al.
Julkaistu: (2006)

Insulin resistance, dyslipidemia and the risk of Alzheimer's disease: A case-control study
Tekijä: Razay, G, et al.
Julkaistu: (2011)

GALANTHAMINE AND THE TREATMENT OF ALZHEIMERS-DISEASE
Tekijä: Wilcock, G, et al.
Julkaistu: (1993)

Determining a diagnostic algorithm for hyperinsulinaemia
Tekijä: Catherine A.P. Crofts, et al.
Julkaistu: (2019-06-01)

Blood pressure, dementia and Alzheimer's disease: the OPTIMA longitudinal study.
Tekijä: Razay, G, et al.
Julkaistu: (2009)

Hyperinsulinaemia in pregnancy and gestational outcomes: A case series
Tekijä: Sylvia M. North, et al.
Julkaistu: (2022-07-01)

Insights from engraftable immunodeficient mouse models of hyperinsulinaemia
Tekijä: Michelle L. Maugham, et al.
Julkaistu: (2017-03-01)

Severe Diltiazem Poisoning Treated with Hyperinsulinaemia-Euglycaemia and Lipid Emulsion
Tekijä: Nadine Monteiro, et al.
Julkaistu: (2013-01-01)

Hyperinsulinaemia: does it tip the balance toward intrahepatic fat accumulation?
Tekijä: Leanne Hodson, et al.
Julkaistu: (2019-10-01)

Hyperinsulinaemia down-regulates TLR4 expression in the mammalian heart
Tekijä: Melody ede Laat, et al.
Julkaistu: (2014-07-01)

Can the Molar Insulin: C-Peptide Ratio Be Used to Predict Hyperinsulinaemia?
Tekijä: Lynda Guildford, et al.
Julkaistu: (2020-05-01)

Diamel Therapy in Polycystic Ovary Syndrome Reduces Hyperinsulinaemia, Insulin Resistance, and Hyperandrogenaemia
Tekijä: Arturo Hernández-Yero, et al.
Julkaistu: (2012-01-01)

Rethinking Fragility Fractures in Type 2 Diabetes: The Link between Hyperinsulinaemia and Osteofragilitas
Tekijä: Isabella D. Cooper, et al.
Julkaistu: (2021-09-01)

Occurrence of mild cognitive impairment with hyperinsulinaemia in Africans with advanced type 2 diabetes mellitus
Tekijä: J. Bashir, et al.
Julkaistu: (2022-06-01)

Correlation of serum homocysteine levels and hyperinsulinaemia with body mass index in polycystic ovarian syndrome
Tekijä: Rashmi Bhushan, et al.
Julkaistu: (2022-01-01)

Body iron status and association with hyperinsulinaemia and hyperandrogenism in non-obese Indian women with polycystic ovarian syndrome
Tekijä: P. Supriya, et al.
Julkaistu: (2012-01-01)

Treatment for Alzheimer's disease.
Tekijä: Wilcock, G
Julkaistu: (2000)

Neurotrophins in Alzheimer's disease
Tekijä: Wilcock, G
Julkaistu: (2002)

TACRINE AND LECITHIN IN ALZHEIMERS-DISEASE
Tekijä: Wilcock, G
Julkaistu: (1990)

Alzheimer's disease--current issues.
Tekijä: Wilcock, G
Julkaistu: (1988)

Demographic, morphologic, hormonal and metabolic factors associated with the rate of improvement from equine hyperinsulinaemia-associated laminitis
Tekijä: Martin Sillence, et al.
Julkaistu: (2022-01-01)

Effects of an anti-IGF-1 receptor monoclonal antibody on laminitis induced by prolonged hyperinsulinaemia in Standardbred horses.
Tekijä: Samira Rahnama, et al.
Julkaistu: (2020-01-01)

Endothelial cell apoptosis in brown adipose tissue of rats induced by hyperinsulinaemia: the possible role of TNF-α
Tekijä: M. Markelic, et al.
Julkaistu: (2011-11-01)

Hypothyroidism in utero stimulates pancreatic beta cell proliferation and hyperinsulinaemia in the ovine fetus during late gestation
Tekijä: Harris, S, et al.
Julkaistu: (2017)

Treatment of the cholinergic impairment in Alzheimer's disease
Tekijä: Wilcock, G
Julkaistu: (1994)

Age and Alzheimer's disease.
Tekijä: Wilcock, G, et al.
Julkaistu: (1983)

Treating Alzheimer's disease.
Tekijä: Wilcock, G, et al.
Julkaistu: (1995)

Velnacrine for Alzheimer's disease.
Tekijä: Birks, J, et al.
Julkaistu: (2004)

Current approaches to the treatment of Alzheimer's disease.
Tekijä: Wilcock, G
Julkaistu: (1996)

Bapineuzumab in Alzheimer's disease: where now?
Tekijä: Wilcock, G
Julkaistu: (2010)

Effectiveness of SMS 201-995, a synthetic, long-acting somatostatin analogue, in treatment of quinine-induced hyperinsulinaemia.
Tekijä: Phillips, R, et al.
Julkaistu: (1986)

Chronic glucocorticoid treatment induces hepatic lipid accumulation and hyperinsulinaemia in part through actions on AgRP neurons
Tekijä: Erika Harno, et al.
Julkaistu: (2021-07-01)

THE ROLE OF GROWTH-FACTORS AND NEUROPEPTIDES IN ALZHEIMERS-DISEASE
Tekijä: Wilcock, G
Julkaistu: (1994)

Asymmetry of pathology in Alzheimer's disease.
Tekijä: Wilcock, G, et al.
Julkaistu: (1987)

The olfactory bulbs in Alzheimer's disease.
Tekijä: Esiri, M, et al.
Julkaistu: (1984)

The increasing burden of Alzheimer disease.
Tekijä: Sadik, K, et al.
Julkaistu: (2003)

Tacrine and lecithin in Alzheimer's disease. Negative conclusions not justified.
Tekijä: Wilcock, G
Julkaistu: (1994)

The challenge of Alzheimer's disease--no longer a silent epidemic.
Tekijä: Wilcock, G
Julkaistu: (1988)